Valuation: Stille AB

Market Cap 204.87Cr 21Cr 19Cr 17Cr 16Cr 30Cr 2.05TCr 31Cr 80Cr 1.02TCr 81Cr 79Cr 3.42TCr P/E 2026 *
25.4x
P/E 2027 * 19.1x
Enterprise Value 198.41Cr 21Cr 18Cr 17Cr 15Cr 29Cr 1.99TCr 30Cr 78Cr 988.67Cr 78Cr 76Cr 3.32TCr EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.39x
Free-Float
53.19%
Yield 2026 *
-
Yield 2027 * 0.88%
1 day-2.56%
1 week-9.52%
1 month-12.14%
3 months-4.00%
6 months+32.17%
Current year+16.33%
1 week 227
Extreme 227
249
1 month 227
Extreme 227
274
Current year 143
Extreme 143
283
1 year 143
Extreme 143
283
3 years 94.2
Extreme 94.2
283
5 years 94.2
Extreme 94.2
283
10 years 23.5
Extreme 23.5
283
Manager TitleAgeSince
Chief Executive Officer 48 12/05/2025
Director of Finance/CFO 54 08/12/2025
Chief Operating Officer - 02/01/2026
Director TitleAgeSince
Director/Board Member 66 01/01/2000
Director/Board Member 63 01/01/2021
Director/Board Member 62 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
26/02/26 Buy

Director

543 0.0060%
24/02/26 Buy

Director

540 0.0060%
24/02/26 Buy

Director

75 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-9.52%+0.88%+101.77% 21Cr
-1.51%+6.39%-27.64%-48.05% 1.49TCr
+0.74%+5.94%+35.33%+129.63% 483.77Cr
+1.95%+5.45%+310.09%+216.19% 355.32Cr
-0.94%+6.20%-23.54%-29.02% 264.41Cr
+0.38%+10.71%-21.22%-21.32% 213.23Cr
-2.33%+3.07%-50.15%-64.33% 193.37Cr
-0.75%+3.10%-1.48%-29.26% 130.52Cr
-1.75%-.--%+20.86%+32.28% 97Cr
+4.30%+44.01%+2.92%+6.68% 94Cr
Average -0.25%+6.78%+24.61%+29.46% 334.06Cr
Weighted average by Cap. -0.52%+6.85%+20.30%+13.62%

Financials

2026 *2027 *
Net sales 72Cr 7.59Cr 6.59Cr 6.14Cr 5.63Cr 11Cr 724.09Cr 11Cr 28Cr 360.48Cr 28Cr 28Cr 1.21TCr 80Cr 8.35Cr 7.26Cr 6.75Cr 6.2Cr 12Cr 796.78Cr 12Cr 31Cr 396.67Cr 31Cr 31Cr 1.33TCr
Net income 8.06Cr 84.5L 73.46L 68.37L 62.77L 1.19Cr 81Cr 1.2Cr 3.16Cr 40Cr 3.17Cr 3.1Cr 134.66Cr 11Cr 1.12Cr 97.7L 90.94L 83.49L 1.58Cr 107.29Cr 1.6Cr 4.21Cr 53Cr 4.22Cr 4.13Cr 179.1Cr
Net Debt -6.45Cr -67.67L -58.82L -54.75L -50.27L -94.93L -65Cr -96.4L -2.53Cr -32Cr -2.54Cr -2.49Cr -107.83Cr -15Cr -1.53Cr -1.33Cr -1.24Cr -1.14Cr -2.15Cr -146.13Cr -2.18Cr -5.73Cr -73Cr -5.75Cr -5.62Cr -243.94Cr
Logo Stille AB
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Employees
225
Date Price Change Volume
31/26/31 SEK 228.00 -2.56% 2,414
30/26/30 SEK 234.00 -1.27% 1,011
29/26/29 SEK 237.00 -.--% 4,509
28/26/28 SEK 237.00 -2.47% 3,509
27/26/27 SEK 243.00 -3.57% 3,366
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
228.00SEK
Average target price
285.75SEK
Spread / Average Target
+25.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STIL Stock